Can phthalate and paraben exposure lower androgen signaling?

Environmental exposure to endocrine-disrupting chemicals is recognized as a factor in compromised male endocrine health, which is especially relevant for maintaining hormone balance in older age.

Molecular mechanisms

• Steroidogenesis Suppression: Leydig cells are the primary site of testicular testosterone synthesis. Phthalates, specifically di-2-ethylhexyl phthalate (DEHP) and its metabolite mono-(2-ethylhexyl) phthalate (MEHP), disrupt Leydig-cell steroidogenesis by suppressing essential regulatory genes, including StAR (steroidogenic acute regulatory protein) and CYP11A1, directly reducing testosterone production.
• Androgen Receptor Antagonism: These EDCs directly impair downstream androgen receptor (AR) signaling. In vitro mammalian reporter assays demonstrate that MEHP acts as a potent AR antagonist, with an IC50 as low as 32 nM. Butylparaben also exhibits AR antagonism, though with lower potency, showing an IC50 of approximately 15 µM.

Clinical evidence

• Hormonal Impacts: Human cohort and cross-sectional studies confirm that higher phthalate exposure correlates with lower serum total and free testosterone levels. Elevated exposure is also associated with reductions in the free androgen index and the testosterone-to-luteinizing hormone (LH) ratio.
• Compound Differences: While phthalate-driven Leydig-cell impairment is strongly supported by both mammalian and cohort data, evidence linking parabens directly to Leydig-cell steroidogenesis is less robust and primarily limited to weaker in vitro receptor antagonism.

Bottom line

• Phthalates and parabens impair male androgen signaling through a dual mechanism: disrupting Leydig-cell steroidogenesis to lower systemic testosterone production and directly antagonizing androgen receptors. This combined pathway provides a strong biological explanation for how common environmental exposures can contribute to lower androgen signaling.